Dr Rosemary Habib
Affiliate
Student supervisor
BSc (Advanced) USYD, MPharm (Clinical) USYD, MBBS ANU, FRACP (Medical Oncologist), PhD USYD
rosemary.habib@health.nsw.gov.au
Biography
Dr Rosemary Habib is a medical oncologist and clinician–researcher with extensive experience in cancer care, translational research, education, and health policy. Her clinical practice spans solid tumour oncology with a strong focus on improving equitable access to high-quality cancer care across the continuum, from diagnosis through survivorship and palliative care. Dr Habib is the clinical medical oncology for head and neck cancers in Western Sydney Local Health District (WSLHD). Dr Habib also co-leads clinical management of sarcomas and upper gastrointestinal cancers within WSLHD. She is the lead investigator of an investigator-initiated clinical study examining diabetes and metabolic factors in head and neck cancer, and serves as Principal Investigator for multiple clinical trials across WSLHD.
In addition to her clinical work, Dr Habib is an accomplished researcher with a PhD and a track record of competitive grant funding, peerreviewed publications, and leadership of multi-site collaborative studies. Her research portfolio includes head and neck cancer, sarcoma, colorectal cancer, cholangiocarcinoma, and immunotherapy-related translational research, as well as health services and outcomes research focused on equity, survivorship, and advanced cancer care. She has founded a clinical oncology research database within WSLHD to support clinician-led research and quality improvement, and she leads the PRMS (Patient-Reported Measures Study), a multi-site collaborative project supported by competitive grant funding.
Dr Habib is deeply engaged in education and mentorship, supervising trainees, mentoring early-career clinicians and researchers, and contributing to undergraduate and postgraduate teaching. She serves on multiple ethics, advisory, and governance committees and is a member of the TROG (Trans-Tasman Radiation Oncology Group) Head and Neck Cancer Working Party, contributing to the translation of research evidence into policy and clinical practice.
Her work extends beyond academia to community engagement and advocacy, with a particular interest in addressing disparities in cancer outcomes and improving models of care for patients with advanced disease.
Dr Habib is recognised for her collaborative leadership style and her commitment to integrating clinical excellence, research innovation, education, and policy to improve outcomes for patients and families affected by cancer.
Research interests
Medical Oncology, Sarcoma, Soft tissue Sarcoma, Head and Neck Cancer, Immunotherapy, CAR-T cell therapy, Proteomics, Cholangiocarcinoma, Bowel cancer, Colorectal cancer, Mass Cytometry, PROMS, PREMS, Clinical trials
Additional information
Phone: 02 98439000
Can also be found here – Dr Rosemary Habib | Ramsay Health Care
Current grants
| NHMRC Ideas grant (2025) | 2025 | |
| Medical Kickstarter Grant, WSLHD (2024) | 2024 | |
| Australia and New Zealand Sarcoma Association Research Grant Recipient (2024) | 2024 | |
| Joyce Anderson Palliative Care Award (2024) | 2023 | |
| Sydney Cytometry User Scheme Grant (2023) | 2023 | |
| Sydney West Translational Cancer Research Centre Infrastructure Fund (2019- 2021) | 2019-2021 |
Affiliations
USYD, Westmead and Blacktown Hospitals.
Professional Associations and Organisations
| Royal Australasian College of Physicians | ||
| Trans Tasman Radiation Oncology Group (TROG) Cancer Research (Working Party Member) | ||
| American Society of Clinical Oncology (ASCO) | ||
| European Society for Medical Oncology (ESMO) | ||
| International Society for Cell & Gene Therapy (ISCT) | ||
| European Society for Radiotherapy and Oncology (ESTRO) | ||
| Australia and New Zealand Head and Neck Cancer Society (ANZHNCS) |
